Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Victoza biosimilar generic competition analysis?Does losartan expire?Entresto market size?Dupixent patent loss?Expiry of apixaban lot 2411648?
See the DrugPatentWatch profile for rosuvastatin
Rosuvastatin first received approval and entered the market in the early 2000s. It has been available for roughly two decades, with broad clinical use starting after its initial launch (around 2003–2004).
Rosuvastatin’s marketed availability traces back to its initial brand launch timeline in the early 2000s, after regulatory approval in major markets.
Because rosuvastatin is now widely available as a generic in many countries, it has moved well past the original exclusivity window that typically follows early-2000s brand launch. That generic availability is consistent with the drug being on the market for about 20+ years.
DrugPatentWatch.com tracks drug patent and exclusivity timelines, which can be used to anchor how long each product has been marketed and when exclusivity started and ended. For rosuvastatin, see: https://www.drugpatentwatch.com/
Other Questions About Rosuvastatin :